Anticancer potential of Amaryllidaceae alkaloids evaluated by screening with a panel of human cells, real-time cellular analysis and Ehrlich tumor-bearing mice

The COSMIC (Catalogue of Somatic Mutations in Cancer) database and website

Sally Bamford, Elisabeth Dawson, Simon Forbes et al. · British Journal of Cancer · 2004 · 1.3K citations · Full text

Mutations in the p53 Tumor Suppressor Gene: Important Milestones at the Various Steps of Tumorigenesis

Noa Rivlin, Ran Brosh, Moshe Oren et al. · Genes & Cancer · 2011 · 1K citations · Full text

Mutant P53, Various Steps, Oncology +15

Specific P53 mutations are associated with de novo resistance to doxorubicin in breast cancer patients

Turid Aas, Anne‐Lise Børresen, Stephanie Geisler et al. · Nature Medicine · 1996 · 737 citations

Breast Oncology, Breast Cancer Patients, Medicine +9

Lycorine, the Main Phenanthridine Amaryllidaceae Alkaloid, Exhibits Significant Antitumor Activity in Cancer Cells That Display Resistance to Proapoptotic Stimuli: An Investigation of Structure−Activity Relationship and Mechanistic Insight

Delphine Lamoral‐Theys, Anna Andolfi, Gwendoline Van Goietsenoven et al. · Journal of Medicinal Chemistry · 2009 · 256 citations

Twenty-two Lycorine-related Compounds, Mechanistic Insight, Glioma +19

Biological and pharmacological activities of amaryllidaceae alkaloids

Maomao He, Chunrong Qu, Oude Gao et al. · RSC Advances · 2015 · 189 citations

Medicinal Chemistry, Pharmaceutical Chemistry, Biochemistry +11